PLUVICTO PSMA Radioligand Therapy in Santa Monica
Advanced Treatment for Metastatic Castration-Resistant Prostate Cancer (mCRPC)
At Tower Saint John’s Imaging in Santa Monica, we offer Pluvicto (lutetium-177 vipivotide tetraxetan), an innovative radiopharmaceutical therapy designed to treat prostate-specific membrane antigen (PSMA)-positive metastatic castration-resistant prostate cancer (mCRPC). This groundbreaking FDA-approved therapy uses targeted radiation to destroy cancer cells while sparing healthy tissue.
Paired with Locametz (gallium-68 gozetotide) PSMA PET imaging, this theranostic approach enables highly personalized treatment and improved outcomes for advanced prostate cancer patients. Studies show Pluvicto therapy significantly enhances survival rates, delays disease progression, and improves quality of life.
Benefits of Pluvicto PSMA Therapy
- Targeted treatment that focuses radiation on prostate cancer cells expressing PSMA, reducing harm to surrounding healthy tissue.
- Locametz PET scans allow for precise tumor mapping and accurate treatment planning.
- Proven to extend overall survival in patients with advanced metastatic prostate cancer.
- Helps preserve quality of life by reducing systemic side effects typically seen with traditional chemotherapy.
- Delays disease progression and gives patients more time with better management of symptoms.
- Customizes treatment based on individual imaging results, improving precision and personalization.
What to Expect from Pluvicto Treatment
Pluvicto is administered intravenously in a series of outpatient sessions at our Santa Monica imaging center. Prior to treatment, a PSMA PET scan using Locametz is performed to confirm eligibility and localize PSMA-expressing cancer cells. Each treatment delivers targeted radiation to metastatic tumors with minimal impact on surrounding tissue.
Potential Side Effects
While most patients tolerate Pluvicto well, side effects can include fatigue, nausea, and dry mouth due to low PSMA expression in salivary glands. Blood counts are monitored throughout therapy, and minor changes are typically temporary. Our team in Santa Monica provides ongoing support to ensure treatment safety and effectiveness.
Is Pluvicto Right for You?
If you or a loved one has been diagnosed with PSMA-positive mCRPC, schedule a consultation with Tower Saint John’s Imaging in Santa Monica. Our experienced specialists can guide you through diagnosis, imaging, and therapy options tailored to your specific condition.
Contact our office to learn more or to schedule your PSMA PET scan and Pluvicto treatment consultation:
Location: 2202 Wilshire Blvd, Santa Monica, CA 90403
Phone: 310.264.9000
Online: Request an appointment
Learn more: PLUVICTO Official Website